Literature DB >> 9048212

Multiplicity of uses of monoclonal antibodies that define papillomavirus linear immunodominant epitopes.

A B Jenson1, M C Jenson, L Cowsert, S J Ghim, J P Sundberg.   

Abstract

During the last 10 yr, we have derived monoclonal antibodies from animals immunized with denatured bovine papillomaviruses type 1 major capsid (L1) protein, mapped their corresponding immunodominant epitopes to within a single amino acid (aa), and compared the reactivity of authentic L1 proteins to the predicted response by collinear analysis of the aa sequences of the same and other papillomaviruses (PVs). The data obtained from this approach has provided us with new insights into the sensitivity and specificity of the antibody response to viral proteins. We have included here some observations and conclusions that appear to be generic for the immune response, some of which might have applications for working with linear epitopes in other experimental systems.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048212     DOI: 10.1007/BF02786327

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  18 in total

Review 1.  The atomic mobility component of protein antigenicity.

Authors:  J A Tainer; E D Getzoff; Y Paterson; A J Olson; R A Lerner
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

Review 2.  Experimental and theoretical aspects of protein folding.

Authors:  C B Anfinsen; H A Scheraga
Journal:  Adv Protein Chem       Date:  1975

3.  Strategies for epitope analysis using peptide synthesis.

Authors:  H M Geysen; S J Rodda; T J Mason; G Tribbick; P G Schoofs
Journal:  J Immunol Methods       Date:  1987-09-24       Impact factor: 2.303

4.  The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar epitopes on unrelated antigens.

Authors:  D Davis; B Chaudhri; D M Stephens; C A Carne; C Willers; P J Lachmann
Journal:  J Gen Virol       Date:  1990-09       Impact factor: 3.891

5.  Identification of linear epitopes of the BPV-1 L1 protein recognized by sera of infected or immunized animals.

Authors:  A B Jenson; P Lim; S Ghim; L Cowsert; C Olson; L Y Lim; C Farquhar; W Pilacinski
Journal:  Pathobiology       Date:  1991       Impact factor: 4.342

Review 6.  Characterization of the humoral immune response to genital papillomaviruses.

Authors:  D A Galloway; S A Jenison
Journal:  Mol Biol Med       Date:  1990-02

7.  Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides.

Authors:  P S Lim; A B Jenson; L Cowsert; Y Nakai; L Y Lim; X W Jin; J P Sundberg
Journal:  J Infect Dis       Date:  1990-12       Impact factor: 5.226

8.  Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer.

Authors:  I Jochmus-Kudielka; A Schneider; R Braun; R Kimmig; U Koldovsky; K E Schneweis; K Seedorf; L Gissmann
Journal:  J Natl Cancer Inst       Date:  1989-11-15       Impact factor: 13.506

9.  Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins.

Authors:  S A Jenison; J M Firzlaff; A Langenberg; D A Galloway
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

10.  Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata.

Authors:  J W Kreider; M K Howett; S A Wolfe; G L Bartlett; R J Zaino; T Sedlacek; R Mortel
Journal:  Nature       Date:  1985 Oct 17-23       Impact factor: 49.962

View more
  2 in total

1.  Live attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system.

Authors:  María Dolores Juárez-Rodríguez; Lourdes T Arteaga-Cortés; Rebin Kader; Roy Curtiss; Josephine E Clark-Curtiss
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Biogenesis of Yersinia pestis PsaA in recombinant attenuated Salmonella Typhimurium vaccine (RASV) strain.

Authors:  Ascención Torres-Escobar; María Dolores Juárez-Rodríguez; Roy Curtiss
Journal:  FEMS Microbiol Lett       Date:  2009-10-22       Impact factor: 2.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.